Skip to main content
. 2016 Oct 6;6:34604. doi: 10.1038/srep34604

Figure 2. Serum IL-10 is correlated with longitudinal assessments of disease activity in SLE.

Figure 2

(A) Correlation between time-adjusted mean (TAM) serum IL-10 and time adjusted mean SLEDAI-2k (AMS). (B) comparison of TAM IL-10 in serum from patients with or without persistently active disease (PAD), measured by ELISA. (C) Correlation between first visit serum IL-10 with AMS. (D) Comparison of first visit IL-10 in serum from patients with or without persistently active disease (PAD), measured by ELISA. The horizontal line in each dot plot depicts the median.